Friday, June 29, 2012
16 Ways Marijuana Affects The Economy
In honor of 4/20, we had hoped to give you 420 reasons to celebrate. Then we randomly got lazy. So here are, like, 16 reasons instead.
Legalizing marijuana could save the U.S. government $13.7 billion by eliminating prohibition enforcement costs and adding billions in tax revenue, according to a paper by Harvard economist Jeffrey Miron that’s gained the support of more than 300 of his economist peers. Proponents have highlighted the potential economic benefits of legalizing marijuana for years, but the growth and legitimization of medical marijuana dispensaries recently could lend the argument more credibility.
Tax revenue from medical marijuana dispensaries is already giving state and local budgets a much needed boost. Oakland, California, for example, inhaled $1.4 million, or 3 percent of the city's total business tax revenue from medical marijuana dispensaries last year, The New York Times reports. Meanwhile, the states of Colorado, Maine and Oregon have all pulled in added tax revenue from medical marijuana.
If the experience of marijuana growing supplier weGrow is any indication, the marijuana industry could also be a big job creator. The chain has opened stores in California, Arizona and, most recently, Washington D.C. and with each new store 75 indirect jobs are created, according to AZBusiness Magazine. Meanwhile, Harborside Health Center, the biggest medical marijuana dispensary in Oakland, employs 120 people, according to the NYT.
But not everyone is convinced legal marijuna would be such a boon for the economy, namely the federal government. Despite President Obama’s campaign promises to respect state laws concerning medical marijuana, the Department of Justice has recently cracked down. This month, Oaksterdam University, which offers training to medical marijuana growers was raided by federal agents, while the IRS has been targeting medical marijuana businesses since last year.
President Obama said in 2009 “I don't think [legalizing marijuana is] a good strategy to grow our economy” but others seem to disagree.
Thursday, June 28, 2012
Programs that we offer for our patients
Releaf offers!!!:
15min Chair Massage onsite between the hrs of 3pm-5pm every Wednesday...
Offer Free Yoga Certificates for our patients!!!
Acupunture onsite every other Tues of each month hrs 2pm-4pm (sign up begins in Sept)
Wednesday, June 27, 2012
Exclusive: Medical Marijuana Dispensaries No Longer Able to Accept Visa, MasterCard as of July 1
The main national company handling payment processing services for the medical marijuana industry will no longer accept Visa and MasterCard transactions from dispensaries, according to information obtained by MMJ Business Daily.
Electronic Merchant Systems (EMS) – which provides merchant accounts for medical marijuana companies via a partnership with Chesapeake Bank in Virginia – informed its MMJ customers of the decision in an email (see full text at the end of this post). The new policy is effective July 1.
The change covers both credit and debit cards, though the email says dispensary clients can still accept MMJ transactions conducted with Discover cards. EMS plans to send out another letter on Wednesday informing medical marijuana merchants to batch and settle all Visa and MasterCard transactions by June 30. EMS and Chesapeake Bank did not immediately return messages left by MMJ Business Daily.
The move is another blow to the medical marijuana business, which is already struggling with a host of challenges tied to banking and payment processing. Most banks refuse to open or service accounts from dispensaries and related businesses, and American Express cut the industry off last year. With Visa and MasterCard out of the picture now, much of the industry will be forced to adopt an all-cash business model.
While some dispensaries have worked out agreements with their local banks or offered vague, possibly misleading descriptions of their businesses to receive credit card processing services, most centers that currently accept cards use EMS.
Companies that facilitate business between EMS and dispensaries are now scrambling to adapt. Several of these companies contacted for comment about the development said they are touting alternative services such as on-site ATMs, which eliminate the need for patients to carry large amounts of cash when they visit dispensaries. Others are still vowing to offer credit card processing services, though dispensaries should perform their due diligence on companies making these claims.
“There are still legitimate non-cash solutions out there for dispensaries with a walk-in location, but proceed with caution,” said Michael L. Rupkalvis of The Transaction Group, which works with MMJ companies to find payment processing services. “If someone claims they can set up a merchant account for your dispensary, make sure they have medical marijuana dispensary listed as the business type on the application and medical marijuana as the product. Some reps will try and get an account approved by not putting the correct business type on the app, or what’s referred to as miscoding an application.”
Aside from making life harder for medical marijuana businesses, the development could exacerbate security issues for the industry, as dispensaries will now have lots of cash on hand.
“This is a disservice to the industry and communities around this industry,” Roger Neustadt, a principal of 420 Card Processing, said when contacted about the effects this will have on the industry. “The claim (by those opposed to MMJ) is that dispensaries increase crime, and this is going to tail right into that and support that notion because it makes them a bigger target.”
Aaron Smith, executive director of the National Cannabis Industry Association, called on the Treasury Department to quickly step in and remedy the banking situation for MMJ companies.
“The Treasury Department in our estimation has the ability to change regulations without an act of Congress,” Smith said. “It doesn’t make any sense regardless of what your position is on medical marijuana to force these businesses into a cash-only situation.”
Here’s the email EMS sent to its agents:
“In light of recent developments, we wanted to reach out and make you all aware of the latest news regarding Medical Marijuana merchants. Effective July 1st, 2012, MMJ merchants will no longer be able to accept Visa or MasterCard credit or debit cards, however, they can continue to accept Discover. All current MMJ merchants will be receiving a message on their May statements that reads:
[IMPORTANT NOTICE Please be advised that as of July 1, 2012 you will no longer be able to accept Visa and MasterCard credit and debit cards for payment. Discover cards will still be honored. We will contact you in the coming weeks to facilitate this transition. If this situation should change with Visa and MasterCard we will inform you immediately. The process for this transition is simple; all merchants need to do is make sure that they batch and settle their transactions at the end of the day on Saturday, June 30th. On July 1st, only Discover transactions will receive approval. Those merchants who fail to batch and settle on June 30th will receive an RB error and will have to call in to Client Services for assistance.]
We will be mailing a letter around June 20th that informs them of the need to batch and settle. Should you have any questions regarding this matter, please call your Agent Relationship Manager. As we informed the affected merchants, if this situation should change with Visa and MasterCard we will inform you immediately!”
Monday, June 25, 2012
Angel Perales, David Silva, Osvaldo Conde: Calif. Mayor And City Officials Accused Of Pot Shop Bribes

Tuesday, June 19, 2012
How can Medical Cannabis help Post traumatic Stress Disorder

Medical Marijuana Does Not Increase Teen Drug Use, Study Shows

Wednesday, June 13, 2012
National Cancer Institue in support of Medical Marijuana


Tuesday, June 12, 2012
San Francisco's Marijuana Dispensaries Still Don't Cause Crimes, Study Shows
Whenever a new medical marijuana dispensary applies for a San Francisco permit, a troop of naysayers is ready with a predictable script: dispensaries cause crime, harm children, and destroy neighborhoods.
However, the city's Planning Commission tired of this long ago -- because it's simply not based on fact. "We have not had direct testimony of law enforcement that they believe there is an increase in crime in areas because there is medical marijuana dispensaries," Commissioner Michael Antonini said March 1 in response to such claims.
Local zoning decisions are not made based on this misnomer, but federal-level law enforcement moves are. Dispensary-related crime, and instances of this crime near children, are exactly why local United States Attorney Melinda Haag shut some 10 state-legal Bay Area cannabis dispensaries since Oct. 7, 2011.
Haag presented no data along with her claims, and a recent study conducted by UCLA researchers won't help her either. Based on crime trends in Sacramento in 2009, the study found "no observed ... associations between the density of medical marijuana dispensaries and either violent or property crime rates," and further found that dispensary security measures like door guards and security camera may be crime deterrents.
Crime predictions are often based on "routine activity theory," the study says. According to this theory, crime will occur when several condition are met: "The presence of a motivated offender; a suitable target defined by its value, visibility, access, and/or likelihood of low resistance to crime; and the absence of guardians against crime."
Researchers Nancy Kepple and Bridget Freisthler looked at other crime-causing variables including employment, young men, and vacant housing. They crunched the numbers and found no discernible link.
"[D]ispensaries may be associated with crime but no more than any other facility in a commercially zoned area with conditions that facilitate crime," they wrote. That is not causal, and they did not factor "guardianship" -- i.e. security cameras, doormen -- in their study. If they did, one could extrapolate that dispensaries in fact reduce crime.
"If medical marijuana dispensaries have strong guardianship, such as security and monitoring systems, routine activity theory would suggest that the three necessary conditions for crime are not met," the researchers wrote.
The researchers stop far short of proclaiming any kind of direct relationship, but note that "these findings run contrary to public perceptions," notably a report from the California Police Chiefs Association, which says doom, gloom, and thugs with guns inevitably follow the opening of a pot club.
So why does this canard persist? Why do politicians say, "liquor store yes -- pot club, no"?
An Oakland dispensary owner we talked to about the study recently suggested another problem-causing zoning use: schools -- specifically middle or high schools. "These kids are a menace," he said, referring to the teenagers who sometimes engage in vandalism on their way to or from a downtown charter school. "Ask anyone one this block who'd they rather be near."
Hmm. We hear much about how the crackdown is intended to "save the children" -- but who then is saving us from the children?
We put in a request to SFPD to discuss the current study, but haven't yet heard back. We will update when we do. In the meantime, we're left with the 2009 white paper from the California Police Chiefs Association, which stated unequivocally that dispensaries are nothing but trouble.
Confirmation bias is a hell of a drug.
Thursday, June 7, 2012
Marijuana Recipes: 'High Times Cannabis Cookbook' Author Gives Edible Weed Advice


Wednesday, June 6, 2012
Medical Marijuana helps Anorexia


Tuesday, June 5, 2012
Recent Research on Medical Marijuana
Emerging Clinical Applications For Cannabis & Cannabinoids
Humans have cultivated and consumed the flowering tops of the female cannabis plant, colloquially known as marijuana, since virtually the beginning of recorded history. Cannabis-based textiles dating to 7,000 B.C.E have been recovered in northern China, and the plant's use as a medicinal and mood altering agent date back nearly as far. In 2008, archeologists in Central Asia discovered over two-pounds of cannabis in the 2,700-year-old grave of an ancient shaman. After scientists conducted extensive testing on the material's potency, they affirmed, "[T]he most probable conclusion ... is that [ancient] culture[s] cultivated cannabis for pharmaceutical, psychoactive, and divinatory purposes."
Modern cultures continue to indulge in the consumption of cannabis for these same purposes, despite a present-day, virtual worldwide ban on the plant's cultivation and use. In the United States, federal prohibitions outlawing cannabis' recreational, industrial, and therapeutic use were first imposed by Congress under the Marihuana Tax Act of 1937 and then later reaffirmed by federal lawmakers' decision to classify marijuana -- as well as all of the plant's organic compounds (known as cannabinoids) -- as a Schedule I substance under the Controlled Substances Act of 1970. This classification, which asserts by statute that cannabis is equally as dangerous to the public as is heroin, defines cannabis and its dozens of distinct cannabinoids as possessing 'a high potential for abuse, ... no currently accepted medical use, ... [and] a lack of accepted safety for the use of the drug ... under medical supervision.' (By contrast, cocaine and methamphetamine -- which remain illicit for recreational use but may be consumed under a doctor's supervision -- are classified as Schedule II drugs; examples of Schedule III and IV substances include anabolic steroids and Valium respectively, while codeine-containing analgesics are defined by a law as Schedule V drugs, the federal government's most lenient classification.) In July 2011, the Obama Administration rebuffed an administrative inquiry seeking to reassess cannabis' Schedule I status, and federal lawmakers continue to cite the drug's dubious categorization as the primary rationale for the government's ongoing criminalization of the plant and those who use it.
Nevertheless, there exists little if any scientific basis to justify the federal government's present prohibitive stance and there is ample scientific and empirical evidence to rebut it. Despite the US government's nearly century-long prohibition of the plant, cannabis is nonetheless one of the most investigated therapeutically active substances in history. To date, there are over 20,000 published studies or reviews in the scientific literature pertaining to the cannabis plant and its cannabinoids, nearly one-third of which were published within the last three years. This total includes over 2,700 separate papers published in 2009, 1,950 papers published in 2010, and another 2,100 published to date in 2011 (according to a key word search on the search engine PubMed Central, the US government repository for peer-reviewed scientific research). While much of the renewed interest in cannabinoid therapeutics is a result of the discovery of the endocannabinoid regulatory system (which we describe in detail later in this booklet), some of this increased attention is also due to the growing body of testimonials from medical cannabis patients and their physicians.
The scientific conclusions of the overwhelmingly majority of modern research directly conflicts with the federal government's stance that cannabis is a highly dangerous substance worthy of absolute criminalization.
For example, in February 2010 investigators at the University of California Center for Medicinal Cannabis Research publicly announced the findings of a series of randomized, placebo-controlled clinical trials on the medical utility of inhaled cannabis. The studies, which utilized the so-called 'gold standard' FDA clinical trial design, concluded that marijuana ought to be a "first line treatment" for patients with neuropathy and other serious illnesses.
Among the studies conducted by the Center, four assessed smoked marijuana's ability to alleviate neuropathic pain, a notoriously difficult to treat type of nerve pain associated with cancer, diabetes, HIV/AIDS, spinal cord injury and many other debilitating conditions. Each of the trials found that cannabis consistently reduced patients' pain levels to a degree that was as good or better than currently available medications.
Another study conducted by the Center's investigators assessed the use of marijuana as a treatment for patients suffering from multiple sclerosis. That study determined that "smoked cannabis was superior to placebo in reducing spasticity and pain in patients with MS, and provided some benefit beyond currently prescribed treatments."
Around the globe, similarly controlled trials are also taking place. A 2010 review by researchers in Germany reports that since 2005 there have been 37 controlled studies assessing the safety and efficacy of marijuana and its naturally occurring compounds in a total of 2,563 subjects. By contrast, many FDA-approved drugs go through far fewer trials involving far fewer subjects.
As clinical research into the therapeutic value of cannabinoids has proliferated so too has investigators' understanding of cannabis' remarkable capability to combat disease. Whereas researchers in the 1970s, 80s, and 90s primarily assessed cannabis' ability to temporarily alleviate various disease symptoms -- such as the nausea associated with cancer chemotherapy -- scientists today are exploring the potential role of cannabinoids to modify disease.
Of particular interest, scientists are investigating cannabinoids' capacity to moderate autoimmune disorders such as multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease, as well as their role in the treatment of neurological disorders such as Alzheimer's disease and amyotrophic lateral sclerosis (a.k.a. Lou Gehrig's disease.) In fact, in 2009, the American Medical Association (AMA) resolved for the first time in the organization's history "that marijuana's status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines."
Investigators are also studying the anti-cancer activities of cannabis, as a growing body of preclinical and clinical data concludes that cannabinoids can reduce the spread of specific cancer cells via apoptosis (programmed cell death) and by the inhibition of angiogenesis (the formation of new blood vessels). Arguably, these latter findings represent far broader and more significant applications for cannabinoid therapeutics than researchers could have imagined some thirty or even twenty years ago.
THE SAFETY PROFILE OF MEDICAL CANNABIS
Cannabinoids have a remarkable safety record, particularly when compared to other therapeutically active substances. Most significantly, the consumption of marijuana -- regardless of quantity or potency -- cannot induce a fatal overdose. According to a 1995 review prepared for the World Health Organization, "There are no recorded cases of overdose fatalities attributed to cannabis, and the estimated lethal dose for humans extrapolated from animal studies is so high that it cannot be achieved by ... users."
In 2008, investigators at McGill University Health Centre and McGill University in Montreal and the University of British Columbia in Vancouver reviewed 23 clinical investigations of medical cannabinoid drugs (typically oral THC or liquid cannabis extracts) and eight observational studies conducted between 1966 and 2007. Investigators "did not find a higher incidence rate of serious adverse events associated with medical cannabinoid use" compared to non-using controls over these four decades.
That said, cannabis should not necessarily be viewed as a 'harmless' substance. Its active constituents may produce a variety of physiological and euphoric effects. As a result, there may be some populations that are susceptible to increased risks from the use of cannabis, such as adolescents, pregnant or nursing mothers, and patients who have a family history of mental illness. Patients with hepatitis C, decreased lung function (such as chronic obstructive pulmonary disease), or who have a history of heart disease or stroke may also be at a greater risk of experiencing adverse side effects from marijuana. As with any medication, patients should consult thoroughly with their physician before deciding whether the medical use of cannabis is safe and appropriate.

Subscribe to:
Posts (Atom)